MARQUE training to reduce agitation in dementia in care homes

shutterstock_1470511052

A group of UCL Mental Health Masters students summarise an RCT on the clinical and cost-effectiveness of the MARQUE intervention (Managing Agitation and Raising Quality of Life) for agitation in people with dementia in care homes.

[read the full story...]

Compulsory Community Treatment does not reduce readmissions or length of stay in hospital

artyom-kulikov-201848-unsplash

John Baker explores a systematic review of compulsory community treatment to reduce readmission to hospital and increase engagement with community care in people with mental illness.

[read the full story...]

Reminiscence therapy for people living with dementia: Cochrane review is inconclusive

anita-jankovic-606752-unsplash

Liz Collier and Solomon Towuru summarise the recently updated Cochrane systematic review on reminiscence therapy for dementia, which includes evidence showing that reminiscence therapy may improve quality of life, cognition, communication and possibly mood in people with dementia in some circumstances, although all the benefits were small.

[read the full story...]

Diabetic patients: does periodontal treatment improve glycaemic control?

shutterstock_2584741

91 diabetic patients were randomised to non-surgical scaling and root planing and amoxicillin or control. While periodontal status significantly improved at 3 months there was no no significant effects on
glycaemic control.

[read the full story...]

A roadmap to advance dementia research and care by 2025

treasure-map-1850653_1280

Clarissa Giebel unfolds and reviews a new roadmap to advance dementia research in prevention, diagnosis, intervention and care by 2025.

[read the full story...]

Loneliness in psychosis and related psychological and social factors

iz-zy-140216-unsplash

Jingyi Wang publishes her debut blog on a recent systematic review of loneliness in psychosis, which shows that the relationship between loneliness and psychosis remains poorly understood due to a lack of high quality studies.

[read the full story...]

CBT for anxiety: new meta-analysis confirms significant improvements to target symptoms

CBT plus taper is effective at reducing benzodiazepine use in the short term (3 months) but this effect is not sustained at 6 months.

Inês Pote summarises a recent meta-analysis of randomised placebo-controlled trials of cognitive behavioural therapy for anxiety and related disorders.

[read the full story...]

Person-centred care for dementia: impact on quality of life, agitation and antipsychotic use

4084079896_8eb54c3e0c_o

Hilary Shepherd reports on a recent paper from the WHELD trial on the impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes.

[read the full story...]

Antipsychotic effectiveness: the numbers don’t lie, check the scoreboard

Screen Shot 2018-03-12 at 15.16.57

Students and Teachers from the King’s College London PNoMH Distance Learning MSc summarise a major new meta-analysis that brings together the last 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia.

[read the full story...]

Community treatment orders and social outcomes in psychosis

16-year-old_black_man

Ian Cummins considers the findings of a recent 48-month follow-up study of social outcomes for patients with psychosis, which concludes that community treatment orders did not offer any long term benefits.

[read the full story...]